Knight Cancer Institute at Oregon Health Sciences University (OHSU)

Site:	Knight Cancer Institute at Oregon Health Sciences University (OHSU)	Go to their website
Address:	3181 S.W. Sam Jackson Park Rd.
City:	Portland
State:	OR
Zip:	97239
Country:	USA

Phase	Trial	Trial Status	Site Status	Drug [asc]	NCT#
3	Study of Regorafenib as a 3rd-line or Greater Treatment for Gastrointestinal Stromal Tumors (GIST) (GRID)	Ongoing, but not recruiting	Closed	Regorafenib (BAY 73-4506)	NCT01271712
2	A Study Evaluating STA-9090 in Patients With Metastatic and/or Unresectable Gastrointestinal Stromal Tumor (GIST)	Completed	Closed	STA-9090	NCT01039519
2	Temozolomide (TMZ) In Advanced Succinate Dehydrogenase (SDH)-Mutant/Deficient Gastrointestinal Stromal Tumor	Active, not recruiting	Active	Temozolomide	NCT03556384
1/2	A Study of THE-630 in Patients With Advanced Gastrointestinal Stromal Tumors (GIST)	Active, not recruiting	Closed	THE-630	NCT05160168